Experts evaluate promising Ebola treatments, including vax candidate from Oxford/Serum Institute

Advisory groups convened by the World Health Organization have considered promising candidates for prioritisation and evaluation in clinical trials, including a candidate vaccine ChAdOx1 Bundibugyo being developed by Oxford University/Serum Institute of India. The vaccine could potentially become available within two to three months for efficacy assessment through a clinical trial, said the WHO

Raccontata daeconomictimes.indiatimes.combusinessday.ngarabnews.comthecitizen.co.tzthehindubusinessline.comstandardmedia.co.ke